Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4633761 | 1.00 | CASP1 (0.54) | CASP1ADRB2ADRB1TSHRSMN1; SMN2 | |
| SCHEMBL30290820 | 1.00 | CASP1 (0.54) | CASP1ADRB2ADRB1TSHRSMN1; SMN2 | |
| SCHEMBL29572016 | 0.82 | CASP1 (0.56) | CASP1ADRB2ADRB1NPC1ALDH1A1 | |
| SCHEMBL22939 | 0.82 | CASP1 (0.56) | CASP1ADRB2ADRB1NPC1ALDH1A1 | |
| SCHEMBL29572218 | 0.82 | CASP1 (0.56) | CASP1ADRB2ADRB1NPC1ALDH1A1 | |
| SCHEMBL3685278 | 0.82 | CASP1 (0.56) | CASP1ADRB2ADRB1NPC1ALDH1A1 | |
| SCHEMBL31506886 | 0.82 | CASP1 (0.56) | CASP1ADRB2ADRB1NPC1ALDH1A1 | |
| SCHEMBL253615 | 0.82 | CASP1 (0.56) | CASP1ADRB2ADRB1NPC1ALDH1A1 | |
| SCHEMBL4632797 | 0.79 | CASP1 (0.70) | CASP1ADRB2ADRB1TSHRNPC1 | |
| SCHEMBL4632799 | 0.79 | CASP1 (0.70) | CASP1ADRB2ADRB1TSHRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | DAIICHI FINE CHEMICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1930441-A1 | METHOD FOR PRODUCTION OF OPTICALLY ACTIVE -HYDROXYCARBOXYLIC ACID | Daiichi Fine Chemical Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311636-A1 | Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid | PCCA, HCAR1, HCAR2 | CASP1 333/4885ADRB2 4593/4885ADRB1 4142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.